NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, par value, $0.001 per share (NMTC) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2021 to Q4 2025

Type / Class
Equity / Common Stock, par value, $0.001 per share
Symbol
NMTC on Nasdaq
Shares outstanding
50,013,453
Price per share
$0.76
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
11,004,939
Total reported value
$8,341,849
% of total 13F portfolios
0%
Share change
-465,897
Value change
-$473,886
Number of holders
28
Price from insider filings
$0.76
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, par value, $0.001 per share (NMTC) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
MERCHANT ADVENTURE FUND, L.P. 14% $2,478,000 4,200,000 MERCHANT ADVENTURE FUND, L.P. 31 Dec 2024
Bleichroeder LP 8% $2,800,000 4,000,000 Bleichroeder LP 30 Jun 2025
Sio Capital Management, LLC 4.7% -34% $2,098,132 -$1,033,699 2,360,635 -33% Sio Capital Management, LLC 30 Sep 2025
AWM Investment Company, Inc. 4.8% $1,388,959 2,354,167 AWM Investment Company, Inc. 31 Mar 2025
MANCHESTER MANAGEMENT CO LLC 4.9% $934,166 1,583,332 JAMES E. BESSER 31 Dec 2024
LYTTON LAURENCE W 2.6% $764,220 1,295,288 LYTTON LAURENCE W 31 Mar 2025
Nantahala Capital Management, LLC 2.6% $471,270 798,762 Nantahala Capital Management, LLC 30 Sep 2024

As of 31 Dec 2025, 28 institutional investors reported holding 11,004,939 shares of NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, par value, $0.001 per share (NMTC). This represents 22% of the company’s total 50,013,453 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, par value, $0.001 per share (NMTC) together control 25% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Bleichroeder LP 8% 4,000,000 0% 0.53% $3,032,000
BARD ASSOCIATES INC 3.7% 1,846,996 -0.22% 0.36% $1,400,023
VANGUARD GROUP INC 3.2% 1,578,237 0% 0% $1,196,303
PERKINS CAPITAL MANAGEMENT INC 2.9% 1,473,000 +0.34% 0.89% $1,116,534
Sio Capital Management, LLC 2.3% 1,140,040 -52% 0.14% $864,150
RENAISSANCE TECHNOLOGIES LLC 1.5% 763,028 +10% 0% $578,375
GEODE CAPITAL MANAGEMENT, LLC 1% 504,510 +1.5% 0% $382,471
ESSEX INVESTMENT MANAGEMENT CO LLC 0.38% 188,427 0.02% $142,828
Cambridge Investment Research Advisors, Inc. 0.34% 171,000 +41% 0% $130,000
NORTHERN TRUST CORP 0.22% 112,123 0% 0% $84,989
XTX Topco Ltd 0.17% 85,454 +321% 0% $64,774
JANE STREET GROUP, LLC 0.12% 62,312 -42% 0% $47,232
STATE STREET CORP 0.12% 59,499 0% 0% $45,100
MAI Capital Management 0.1% 50,000 0% 0% $37,900
BLAIR WILLIAM & CO/IL 0.1% 48,056 -13% 0% $36,426
Squarepoint Ops LLC 0.1% 47,968 0% $36,360
Legato Capital Management LLC 0.09% 44,329 0% $33,601
CITADEL ADVISORS LLC 0.09% 44,294 -79% 0% $33,575
J.W. COLE ADVISORS, INC. 0.07% 36,000 -3% 0% $27,288
Focus Financial Network, Inc. 0.07% 34,722 0% 0% $26,319
ACADIAN ASSET MANAGEMENT LLC 0.06% 28,135 0% $21,000
GOLDMAN SACHS GROUP INC 0.05% 26,764 0% $20,287
MORGAN STANLEY 0.05% 25,984 +108% 0% $19,696
United Community Bank 0.04% 20,000 0.01% $15,160
Princeton Global Asset Management LLC 0.03% 16,833 0% 0% $12,759

Institutional Holders of NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, par value, $0.001 per share (NMTC) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 11,004,939 $8,341,849 -$473,886 $0.76 28
2025 Q3 14,406,380 $12,801,427 +$798,232 $0.89 34
2025 Q2 13,532,500 $9,178,137 +$7,852,763 $0.68 30
2025 Q1 1,929,327 $1,640,294 +$267,014 $0.85 18
2024 Q4 1,618,518 $1,336,454 -$822,631 $0.83 20
2024 Q3 2,423,467 $2,399,034 -$268,422 $0.99 21
2024 Q2 2,735,360 $2,187,702 -$97,024 $0.80 18
2024 Q1 2,846,820 $3,416,201 -$33,927 $1.20 18
2023 Q4 2,862,898 $4,523,339 +$578,694 $1.58 20
2023 Q3 2,618,184 $2,331,807 +$1,492,764 $0.89 18
2023 Q2 938,623 $1,126,777 -$44,391 $1.20 13
2023 Q1 962,913 $1,549,540 +$453,337 $1.61 14
2022 Q4 722,249 $866,359 +$155,582 $1.20 18
2022 Q3 409,378 $686,000 +$3,717 $1.69 9
2022 Q2 479,839 $394,000 -$269,817 $0.82 8
2022 Q1 707,048 $777,000 -$2,285,922 $1.10 8
2021 Q4 1,946,125 $3,774,000 +$3,070,716 $1.94 12
2021 Q3 250,733 $989,000 -$398,000 $3.94 6
2021 Q2 411,124 $1,522,205 +$1,521,000 $6.63 3